
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
| JACKS, TYLER | WIP-376 CHARACTERIZATION OF PERP, A NOVEL p53 APOPTOSIS-SPECIFIC TARGET GENE . Ihrie, Rebecca1, Horner, Jennifer1, Khachatrian, Leili2, Reczek, Elizabeth2, Sage, Julien2, Jacks, Tyler2,3, Attardi, Laura*,1, 1 Department of Radiation Oncology, Stanford, CA2 Department of Biology, Cambridge, MA3 Howard Hughes Medical Institute, Cambridge, MA |
| JACKSON, STEPHEN | P17-160 Persistent ATM activation in Ku80-/- fibroblasts. Burma, Sandeep*,1, Kurmasa, Akihiro2, Cary, Robert3, Iliakis, George4, Li, Gloria5, Jackson, Stephen6, Chen, David1, 1 Lawrence Berkeley National Laboratory, Berkeley, CA2 Tottori University, Tottori, JAPAN3 Los Alamos Laboratory, Los Alamos, NM4 Thomas Jefferson University, Philadelphia, PA5 Memorial Sloan-Kettering Cancer Center, New York, NY6 Wellcome/CRC Institute, University of Cambridge, Cambridge, UK |
| JACKSON, ANDREW | S06-1 Volume effects in late rectal bleeding after external beam radiotherapy for prostate cancer. Jackson, Andrew*,1, 1 Department of Medical Physics, New York, New York |
| JACKSON, J. | P23-255 Low Doses of Radiation Increase the Latency of Spontaneous Cancers in Cancer Prone Trp53 Heterozygous Mice. Mitchel, R.*,1, Jackson, J.1, Carlisle, S.1, 1 Atomic Energy of Canada Limited, Chalk River, ON Canada |
| JACKSON, WILLIAM | P19-185 Biodosimetry strategy for potential radiation casualty events. Prasanna, Pataje*,1, Subramanian, Uma1, Greenhill, R.1, Muderhwa, J.1, Grace, M.1, Levine, Ira1, Goans, Ronald2, Lloyd, D.1, Loats, Harry3, Jackson, William1, Salter, C.1, Jacocks, John1, Blakely, William1, 1 Armed Forces Radiobiology Research Institute, 8901 Wisconsin Ave., Bethesda, MD2 Radiation Emergency Assistance Center/Training Site, P.O. Box 117, MS 39, Oak Ridge, TN3 Loats Associates, Westminster, MD |
| JACKSON, WILLIAM | P12-115 Effects of the novel systemic radioprotectant 5-androstenediol on phagocytosis and oxidative burst in monocytes and granulocytes from mice exposed to whole-body gamma-irradiation. Whitnall, Mark*,1, Villa, Vilmar1, Benjack, James1, Miner, Venita1, Seed, Thomas1, Jackson, William1, 1 Radiation Casualty Management Team, Bethesda, MD |
| JACOB, PETER | WIP-390 Modeling of carcinogenesis and uncertainty of radiation risk estimates at low doses. Jacob, Peter*,1, Prokic, Vesna1, 1 GSF - Institute of Radiation Protection, Neuherberg, Germany |
| JACOBSEN, SVEIN | MP03-24 SAR pattern perturbations from resonance effects in water bolus layers used with superficial microwave hyperthermia applicators. Neuman, Daniel*,1, Stauffer, Paul1, Jacobsen, Svein2, 1 Radiation Oncology Department, San Francisco, C2 Institute of Physics, Tromso, Norway |
| JACOCKS, JOHN | P19-185 Biodosimetry strategy for potential radiation casualty events. Prasanna, Pataje*,1, Subramanian, Uma1, Greenhill, R.1, Muderhwa, J.1, Grace, M.1, Levine, Ira1, Goans, Ronald2, Lloyd, D.1, Loats, Harry3, Jackson, William1, Salter, C.1, Jacocks, John1, Blakely, William1, 1 Armed Forces Radiobiology Research Institute, 8901 Wisconsin Ave., Bethesda, MD2 Radiation Emergency Assistance Center/Training Site, P.O. Box 117, MS 39, Oak Ridge, TN3 Loats Associates, Westminster, MD |
| JAFFRAY, DAVID | P32-313 An image guided small animal conformal radiation research platform. Wong, John*,1, Jaffray, David1, Siewerdsen, Jeff1, Oldham, Mark1, Laub, Wolfram1, Armour, Elwood1, 1 Deptment of Radiation Oncology, Royal Oak, MI |
| JAIN, RAKESH | P08-65 Glomerulopathy in mice treated with whole-body irradiation and VEGFR2-blocking antibody. Kozin, Sergey*,1, Boucher, Yves1, di Tomaso, Emmanuelle1, Padera, Timothy1, Xavier, Ramnik1, Hicklin, Daniel2, Bohlen, Peter2, Jain, Rakesh1, 1 Massachusetts General Hospital, Boston, MA2 ImClone Systems, Inc., New York, NY |
| JAIN, SUSHIL | P12-108 Radioprotection by vitamin E and its pharmacokinetic profile. Kumar, K. Sree*,1, Jain, Sushil2, Srinivasan, Venkataraman1, Toles, Raymond1, Seed, Thomas1, 1 Radiation Casualty Management Team, Bethesda, MD2 Department of Pediatrics, Shreveport, LA |
| JAIN, VINEY | P06-49 Monitoring of early radiation responses with P-31 magnetic resonance spectroscopy in Ehrlich ascites tumor cells. Sharma, Rakesh*,1, Jain, Viney2,3, 1 Institute of Nuclear Medicine and Allied Sciences, Delhi, India2 Wallace-Kettering Neuroscience Institute, Kettering, OH3 Department of Emergency Medicine, Kettering, OH |
| JAIN, VINEY | P13-123 Radiosensitization of Ehrlich ascites tumor cells by DNA ligand H-33342 in vitro and in vivo. Dwarakanath, Bilikere*,1, Gupta, Seema1, Tripathi, Neelima1, Adhikari, Jawahar1, Chandna, Sudhir1, Mathew, T. Lazar, Jain, Viney2,3, 1 Institute of Nuclear Medicine and Allied Sciences, Delhi, India2 Wallace-Kettering Neuroscience Institute, Kettering, OH3 Department of Emergency Medicine, Kettering, OH |
| JAIN, VIPAN | P11-93 Radiation-induced acute blood-brain barrier disruption is mediated by the acid sphingomyelinase pathway . Li, Yu-Qing*,1, Jain, Vipan1, Haimovitz-Friedman, Adriana2, Wong, Shun1, 1 Princess Margaret Hospital, Toronto, Ontario, Canada2 Memorial Sloan-Kettering Cancer Center, New York, NY |
| JAKOB, BURKHARD | P17-176 DNA damage response proteins localize to foci along tracks of particle-induced damage. Taucher-Scholz, Gisela*,1, Jakob, Burkhard1, Scholz, Michael1,2, Kraft, Gerhard1, 1 Dept. of Biophysics, Darmstadt, Germany2 Radiologische Klinik, Heidelberg, Germany |
| JAKOB, BURKHARD | S19-1 Biological Visualization of Single Charged Particle Tracks. Taucher-Scholz, Gisela*,1, Jakob, Burkhard1, Borgiel, Yvonne1, Scholz, Michael2, 1 Biophysik, Darmstadt, Germany2 Radiologische Klinik, Heidelberg, Germany |
| JALALI, FARID | P20-213 Ser15-phosphorylated p53: a Sensor of DNA damage. Al Rashid, Shahnaz*,1,3, Jalali, Farid1,3, Lilge, Lothar1,3, Benchimol, Sam1,3, Bristow, Robert1,2,3, 1 Ontario Cancer Institute-Princess Margaret Hospital (UHN), Toronto, Ontario3 Department of Medical Biophysics, University of Toronto, Toronto, Ontario2 Department of Radiation Oncology, University of Toronto, Toronto, Ontario |
| JALALI, FARID | MS12-2 Ser15-phosphorylated p53: a Sensor of DNA damage. Al Rashid, Shahnaz*,1,3, Jalali, Farid1,3, Lilge, Lothar1,3, Benchimol, Sam1,3, Bristow, Robert1,2,3, 1 Ontario Cancer Institute-Princess Margaret Hospital (UHN), Toronto, Ontario3 Department of Medical Biophysics, University of Toronto, Toronto, Ontario2 Department of Radiation Oncology, University of Toronto, Toronto, Ontario |
| JAMES, DAVID | P16-151 Effect of EGFR overexpression and mutation in glioma cell lines on sensitivity to EGFR tyrosine kinase inhibitor Tarceva (OSI-774). Krishnan, Sunil*,1, James, David1, Frederick, Lori1, Sarkaria, Jann1, Uhm, Joon1, 1 Mayo Clinic, Rochester, MN |
| JANSSEN, HILDE | P10-90 Study of hypoxia in human head and neck tumors by pimonidazole binding and HIF-1 alpha expression. Janssen, Hilde*,1, Blommestijn, Gerard1, Sprong, Debbie1, Haustermans, Karin1,2, Semenza, Gregg3, Raleigh, Jim4, Balm, Alfons1, Begg, Adrian1, 1 The Netherlands Cancer Institute, Amsterdam, The Netherlands2 University Hospital Gasthuisberg, Leuven, Belgium3 The Johns Hopkins University School of medicine, Baltimore, Maryland4 UNC-CH School of Medicine, Chapel Hill, North Carolina |
| JANSSEN, HILDE | MS05-2 Study of hypoxia in human head and neck tumors by pimonidazole binding and HIF-1 alpha expression. Janssen, Hilde*,1, Blommestijn, Gerard1, Sprong, Debbie1, Haustermans, Karin1,2, Semenza, Gregg3, Raleigh, Jim4, Balm, Alfons1, Begg, Adrian1, 1 The Netherlands Cancer Institute, Amsterdam, The Netherlands2 University Hospital Gasthuisberg, Leuven, Belgium3 The Johns Hopkins University School of medicine, Baltimore, Maryland4 UNC-CH School of Medicine, Chapel Hill, North Carolina |
| JASIN, MARIA | S18-2 Homology-directed repair of double-strand breaks in mammalian cells. Pierce, Andrew*,1, Jasin, Maria1, 1 Cell Biology Program, New York, New York |
| JEFFERSON, MIA | P12-111 Localization of superoxide dismutase to the mitochondria is required for radioprotection of cells in vitro. Epperly, Michael*,1, Gretton, Joan1, Jefferson, Mia1, Bernarding, Michael1, Greenberger, Joel1, 1 Department of Radiation Oncology, Pittsburgh, PA |
| JENKINS, W | P10-85 Modification of Radiation Response by DDFP, a gas-phase perfluorochemical emulsion. Koch, Cameron*,1, Oprysko, Patricia1, Shuman, Lee1, Jenkins, W1, Brandt, Gordon2, Evans, Sydney1, 1 University of Pennsylvania, Phila, Pa2 Sonus Pharmaceuticals, Bothell, Washington |
| JENNER, TERRY | P20-217 Endogenous and radiation-induced clustered DNA lesions revealed as Formamidopyrimidine DNA glycosylase and Endonuclease III sensitive sites. Gulston, Melanie*,1, Jenner, Terry1, de Lara, Catherine1, O'Neill, Peter1, 1 Medical Research Council, Didcot, Oxfordshire |
| JENNER, TERRY | MS08-2 Endogenous and radiation-induced clustered DNA lesions revealed as Formamidopyrimidine DNA glycosylase and Endonuclease III sensitive sites. Gulston, Melanie*,1, Jenner, Terry1, de Lara, Catherine1, O'Neill, Peter1, 1 Medical Research Council, Didcot, Oxfordshire |
| JIRESOVA, ALENA | P11-103 Dose-volume-region effects in partial irradiation of rat lung. Jiresova, Alena*,1, Wiegman, Erwin1, Kampinga, Harm1, Coppes, Rob1, 1 Department of Radiation and Stress Cell Biology, Faculty of Medical Sciences, University of Groningen, Groningen, The Netherlands |
| JIRESOVA, ALENA | MS04-5 Dose-volume-region effects in partial irradiation of rat lung. Jiresova, Alena*,1, Wiegman, Erwin1, Kampinga, Harm1, Coppes, Rob1, 1 Department of Radiation and Stress Cell Biology, Faculty of Medical Sciences, University of Groningen, Groningen, The Netherlands |
| JOBLING, MICHAEL | P09-79 Isoform specificity of redox-mediated TGF- activation.Jobling, Michael*,1, Finnigan, Monica1, Barcellos-Hoff, Mary Helen1, 1 Cell and Molecular Biology, Berkeley, CA |
| JOBLING, MICHAEL | MS05-4 Isoform specificity of redox-mediated TGF- activation.Jobling, Michael*,1, Finnigan, Monica1, Barcellos-Hoff, Mary Helen1, 1 Cell and Molecular Biology, Berkeley, CA |
| JOENSUU, HEIKKI | P11-92 Late radiation effects in the dog brain: correlation of MRI and histological changes. Benczik, Judit*,1, Tenhunen, Mikko2, Snellman, Marjatta1, Joensuu, Heikki2, Kallio, Merja3, Morris, Gerard4, Hopewell, John4, 1 Department of Clinical Veterinary Sciences, Helsinki, Finland2 Department of Oncology, Helsinki, Finland3 Department of Neurology, Helsinki, Finland4 Normal Tissue Radiobiology Research Group, Oxford, United Kingdom |
| JOHNKE, ROBERTA | P22-238 Absorbed integral dose and plasma cytokine expression in patients receiving pelvic radiotherapy. Daly, Barbara1, Evans, Mark1, Johnke, Roberta1, Biggs, Lisa1, Lee, T1, Evans, Scott1, Kovacs, Charles*,1, 1 Division of Radiation Biology & Oncology, Greenville, North Carolina |
| JOHNSON, RANDALL | S10-2 Immediate-early Genes and HIF-1: The Example of c-jun . Laderoute, Keith*,1, Calaoagan, Joy1, Knapp, Merrill1, Johnson, Randall2, 1 Pharmaceutical Discovery Division, Menlo Park, CA2 Depart of Biology, La Jolla, CA |
| JOHNSON, RANDALL | S10-3 Role of hypoxic response in normal and pathological physiology. Johnson, Randall*,1, 1 UC San Diego, La Jolla, CA |
| JOHNSTON, PETER | P15-135 Low dose hyper-radiosensitivity and cell cycle phase. Marples, Brian*,1,2, Short, Susan1, Woodcock, Michael1, Johnston, Peter1, Joiner, Michael1,2, 1 Gray Cancer Institute, Northwood, HA6 2JR2 Karmanos Cancer Institute, Detroit, MI-48201 |
| JOHNSTON, PETER | P17-178 Low dose hyper-radiosensitivity and DNA damage recognition. Johnston, Peter*,1, Marples, Brian1,2, Joiner, Michael1,2, Woodcock, Michael1, Chalmers, Anthony1, Cann, Nansi1, 1 Gray Cancer Institute, Northwood, Middx2 Karmanos Cancer Institute, Detroit, MI |
| JOINER, MICHAEL | P15-135 Low dose hyper-radiosensitivity and cell cycle phase. Marples, Brian*,1,2, Short, Susan1, Woodcock, Michael1, Johnston, Peter1, Joiner, Michael1,2, 1 Gray Cancer Institute, Northwood, HA6 2JR2 Karmanos Cancer Institute, Detroit, MI-48201 |
| JOINER, MICHAEL | S05-5 Low-dose hyper-radiosensitivity: mechanisms and potential impact on radiation therapy and radiation risk. Joiner, Michael*,1, 1 Department of Radiation Oncology, Detroit, MI |
| JOINER, MICHAEL | P17-178 Low dose hyper-radiosensitivity and DNA damage recognition. Johnston, Peter*,1, Marples, Brian1,2, Joiner, Michael1,2, Woodcock, Michael1, Chalmers, Anthony1, Cann, Nansi1, 1 Gray Cancer Institute, Northwood, Middx2 Karmanos Cancer Institute, Detroit, MI |
| JOINER, MICHAEL | P21-227 Chimeric gene promoters responsive to ionizing radiation and hypoxia for use in cancer gene therapy. Greco, Olga1, Marples, Brian*,2, Dachs, Gabi1, Joiner, Michael2, Scott, Simon2, 1 Gray Cancer Institute, Northwood, Middx.2 Karmanos Cancer Institute, Detroit, Michigan |
| JONES, ELLEN | S01-2 Tumor reoxygenation in patients with locally advanced breast carcinoma after neoadjuvant chemotherapy and hyperthermia treatment. Vujaskovic, Zeljko*,1, Blackwell, Kim1, Rosen, Eric1, Jones, Ellen1, Samulski, Thaddeus1, Brizel, David1, Dewhirst, Mark1, Prosnitz, Leonard1, 1 Duke University Medical Center, Durham, NC |
| JONES, ELLEN | P06-48 Comparison of MR imaging and MR spectroscopic parameters with oxygenation, thermometry, and histopathology in 35 patients with high grade soft tissue sarcomas following thermoradiotherapy. Charles, H.2, MacFall, James2, Samulski, Thaddeus1, Brizel, David1, Poulson, Jean1, Yu, Daohai3, Prosnitz, Leonard1, Jones, Ellen1, Dewhirst, Mark1, Lora-Michiels, Michaël*,1, 2 Center for Advanced Magnetic Resonance Development1 Department of Radiation Oncology3 Department of Biostatistics and Bioinformatics, Durham, NC |
| JONES, ELLEN | S01- Current and evolving clinical hyperthermia. Jones, Ellen*,1, Prosnitz, Leonard1, Hurwitz, Mark2, Kalapurakal, John3, Myerson, Robert4, 1 Dept. of Radiation Oncology, Durham, NC2 Brigham & Women's Hospital, Boston, MA3 Northwest Memorial Hospital, Chicago, IL4 Radiation Oncology Center, St. Louis, MO |
| JONES, ELLEN | S01-1 Phase I/II study of liposomal doxorubicin and whole abdomen hyperthermia in refractory ovarian cancer. Jones, Ellen*,1, Prosnitz, Leonard1, Samulski, Thaddeus1, Berchuck, Andrew2, Clarke-Pearson, Daniel2, Alvarez, Angeles2, Soper, John2, Dewhirst, Mark1, 1 Dept. of Radiation Oncology, Durham, NC2 Division of Oncology, Dept. of OB/GYN, Durham, NC |
| JONES, ELLEN | MS05-3 Comparison of MR imaging and MR spectroscopic parameters with oxygenation, thermometry, and histopathology in 35 patients with high grade soft tissue sarcomas following thermoradiotherapy. Charles, H. Cecil2, McFall, James2, Samulski, Thaddeus1, Brizel, David1, Poulson, Jean1, Yu, Daohai3, Prosnitz, Leonard1, Jones, Ellen1, Dewhirst, Mark1, Lora-Michiels, Michaël*,1, 2 Center for Advanced Magnetic Resonance Development1 Department of Radiation Oncology3 Department of Biostatistics and Bioinformatics, Durham, NC |
| JONES, TAMAKO | P22-239 Radiation Induced Gene Expression in the Nematode C. elegans. Jones, Tamako*,1, Chesnut, Aaron1, Bayeta, Erban1, Nelson, Gregory1, 1 Radiobiology Program, Loma Linda, CA |
| JORDAN, ROBERT | P19-193 Genomic instability in TK6 cells after exposure to Cs-137 vs. Fe-56. Evans, Helen*,1, Jordan, Robert2, Horng, Min-Fen1, Ricanati, Marlene1, Schwartz, Jeffrey2, 1 Department of Radiation Oncology, Cleveland, OH2 Department of Radiation Oncology, Seattle, WA |
| JULIEN, TERRANCE | MP04-39 Adenovirus-mediated antisense Ku70 gene transfer increases the radiosensitivity of human malignant gliomas. Fuqiu, He1, Shao, Rachel1, Urano, Muneyasu1, Xu, Ming1, Julien, Terrance1, Borrelli, Mike2, Gutin, Philip1, Li, Gloria*,1, 1 Memorial Sloan-Kettering Cancer Center, New York, NY2 William Beaumont Hospital, Royal Oak, MI |
| JUN, HYUN-JUNG | WIP-384 Comparison of glutathione recycling capacity in the kidney between the radiation-resistant C3H and the radiation-sensitive C57BL/6 strains. Park, Ji-Sun1, Jun, Hyun-Jung1, Sung, Jae-Suk1, Kim, Woo-Chul2, Park, Eun-Mi1, Park, Young-Mee*,1, 1 Division of Chemistry and Biology, Incheon, Korea2 Department of Radiation Oncology, College of Medicine, Incheon, Korea |
| JUNG, HORST | MS11-3 Radiation-induced chromosomal damage predicts the risk of acute reactions after radiotherapy. Borgmann, Kerstin*,1, Bernhard, Michael1, Brackrock, Sophie2, Jung, Horst1, Alberti, Winfried2, Dikomey, Ekkehard1, 1 Institute of Biophysics and Radiobiology, Hamburg, Germany2 Department of Radiotherapy and Radiooncology, Hamburg, Germany |
| JUNG, HORST | P25-268 Radiation-induced chromosomal damage predicts the risk of acute reactions after radiotherapy. Borgmann, Kerstin*,1, Bernhard, Michael1, Brackrock, Sophie2, Jung, Horst1, Alberti, Winfried2, Dikomey, Ekkehard1, 1 Institute of Biophysics and Radiobiology, Hamburg, Germany2 Department of Radiotherapy and Radiooncology, Hamburg, Germany |
| JUNG, MIRA | P29-285 Constitutive activation of NF-kB in K-ras transformed epithelial cells. Kim, Boyeon*,1, Song, Kyung1, Dritschilo, Anatoly1, Gaynor, Richard2, Jung, Mira1, 1 Department of Radiation Medicine, Washington DC, Washington DC2 University of Texas, Dallas, Texas |
| JUNG, MIRA | P20-204 Constitutive expression of acetylated p53 in AT Fibroblasts. Song, Kyung*,1, Dritschilo, Anatoly1, Jung, Mira1, 1 Department of Radiation Medicine, Washington, DC |
| JUNG, MIRA | S21-2 Role of ATM in Chromatin Modification. Jung, Mira*,1, 1 Department of Radiation Medicine, Georgetown University School of Medicine, Washington, DC |
| JUNG, MIRA | S21- Role of ATM and ATR. Jung, Mira*,1, 1 Department of Radiation Medicine, Georgetown University School of Medicine, Washington, DC |
| JUNK, ANNA | P24-257 The lenses of ATM knockout mice are more sensitive to radiation damage than those of wildtypes. Worgul, Basil*,1, Xu, Shang1, Smilenov, Lubomir2, Junk, Anna1, David, Janice1, Hall, Eric2, 1 Eye Radiation & Environmental Research Laboratory, New York, NY2 Center For Radiological Research, New York, NY |